Latest Insider Transactions at Progressive Care Inc. (RXMD)
This section provides a real-time view of insider transactions for Progressive Care Inc. (RXMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Progressive Care Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Progressive Care Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 09
2023
|
Pedro Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,111
+25.97%
|
$44,444
$4.5 P/Share
|
|
Jul 21
2023
|
Jervis Hough Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,311
+17.81%
|
$46,555
$5.37 P/Share
|
|
Jul 01
2023
|
Charles M. Fernandez Chairman & CEO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,443,839
+13.05%
|
$2,887,678
$2.2 P/Share
|
|
Jul 01
2023
|
Charles M. Fernandez Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
600,100
-8.06%
|
$2,400,400
$4.45 P/Share
|
|
Jul 01
2023
|
Rodney Barreto Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,283,839
+11.57%
|
$2,567,678
$2.2 P/Share
|
|
Jul 01
2023
|
Rodney Barreto Director |
SELL
Open market or private sale
|
Indirect |
520,999
-7.02%
|
$1,562,997
$3.89 P/Share
|
|
May 09
2023
|
Charles M. Fernandez Chairman & CEO |
BUY
Conversion of derivative security
|
Indirect |
798,839
+36.48%
|
$1,597,678
$2.2 P/Share
|
|
May 09
2023
|
Charles M. Fernandez Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
455,000
+37.49%
|
$910,000
$2.2 P/Share
|
|
May 09
2023
|
Rodney Barreto Director |
BUY
Conversion of derivative security
|
Indirect |
798,839
+35.77%
|
$1,597,678
$2.2 P/Share
|
|
May 09
2023
|
Rodney Barreto Director |
BUY
Open market or private purchase
|
Indirect |
455,000
+37.04%
|
$910,000
$2.2 P/Share
|
|
Apr 18
2023
|
Pedro Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+42.19%
|
$45,000
$3.16 P/Share
|
|
Apr 18
2023
|
Joseph Ziegler Director |
BUY
Grant, award, or other acquisition
|
Indirect |
15,000
+39.27%
|
$45,000
$3.16 P/Share
|
|
Jan 01
2023
|
Joseph Ziegler Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8,197
+50.0%
|
$49,182
$6.1 P/Share
|
|
Oct 07
2022
|
Alan Jay Weisberg Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000,000
+37.17%
|
-
|
|
Oct 07
2022
|
Birute Norkute Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000,000
+38.13%
|
-
|
|
Jul 21
2022
|
Jervis Hough Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,929
+32.38%
|
$44,645
$5.6 P/Share
|
|
Apr 05
2022
|
Jervis Hough Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+30.84%
|
$45,000
$3.16 P/Share
|
|
Mar 22
2022
|
Joseph Ziegler Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,929
+50.0%
|
$44,645
$5.6 P/Share
|
|
Dec 14
2021
|
Alan Jay Weisberg Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
277,528
+3.14%
|
$0
$0.03 P/Share
|
|
Dec 13
2021
|
Alan Jay Weisberg Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
437,451
+5.01%
|
$0
$0.03 P/Share
|
|
Dec 13
2021
|
Cecile Munnik Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
17,024
+3.1%
|
$0
$0.03 P/Share
|
|
Dec 10
2021
|
Alan Jay Weisberg Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
92,559
+1.16%
|
$0
$0.03 P/Share
|
|
Dec 10
2021
|
Cecile Munnik Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,946
+3.09%
|
$0
$0.03 P/Share
|
|
Dec 09
2021
|
Alan Jay Weisberg Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
692,462
+8.19%
|
$0
$0.03 P/Share
|